Pharma and Life Sciences Blog
NOVEMBER 22, 2023
The environment is marked by heightened demand and expectations, compounded by challenges such as rising input prices, supply chain disruptions and geopolitical tensions. While some embrace cutting-edge tools like AI and blockchain for global trade functions, others lag in technology adoption.
pharmaphorum
NOVEMBER 3, 2021
The report refers to data collected across 350+ global pharma companies between November 2020 through January 2021, and notes a 70% compound average growth rate in the volume of content managed in Veeva Vault PromoMats since 2018.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
epicur
FEBRUARY 23, 2023
Traditional 503A compounding pharmacies and 503B outsourcing manufacturers both serve as important partners for veterinary practices, providing patient-specific prescriptions and manufacturing bulk drugs for in-practice use and dispensing when allowed by state regulations. In many cases, those variances have led to compounding tragedies.
Pharmaceutical Technology
JANUARY 10, 2023
The collaboration will combine 3T Biosciences’ 3T- T-Cell Receptor Antigen and Cross-Reactivity Engine (TRACE) discovery platform with Boehringer Ingelheim’s two-pronged research strategy combining compounds that are directed towards cancer cells and target immune cells.
European Pharmaceutical Review
DECEMBER 21, 2022
Organic compounds are arguably the foundation of the pharmaceutical industry. All traditional small molecule pharmaceuticals include carbon building blocks” Organic compounds are arguably the foundation of the pharmaceutical industry. EFPIA White Paper on Circular Economy, June 2020. Recycling of medical plastics.
Pharmaceutical Technology
FEBRUARY 23, 2023
Our chemists and formulation scientists review the properties of new drug candidates and “work their magic” to develop formulations that improve the exposure profile of the compound. How does bioavailability play a role in biopharmaceutics? Now fraction absorbed and bioavailability are often confused and used interchangeably.
Pharmaceutical Technology
MARCH 6, 2023
Teijin Pharma is laying the foundation for quickly delivering a new therapy for patients globally by licensing the investigational compound to Novartis. It stated that the candidate is believed to impact the pathogenesis of several kidney diseases and works in a genetically validated pathway.
Expert insights. Personalized for you.
52 
Let's personalize your content